
Lysosomal storage diseases (LSDs) are a group of over 50 genetically inherited disorders that are characterized by a deficiency of a vital
enzyme. The lysosome is the cell’s recycling center. When an enzyme does not function properly there is an accumulation of undigested material (
substrate) inside the lysosome leading eventually to cell degeneration. This process results in accumulation of substrate in various tissues and organs of the body causing these organs to function less efficiently, resulting in progressive deterioration in physical and/or mental state, and eventually death.
Individual LSD's are classified as rare genetic disorders. However, when taken as a group, LSD's are far more common, with a prevalence rate of 1 per 7,700* births in some countries.
In healthy cells, large molecules, such as glycolipids and
glycogen, are broken down into functional units by lysosomal enzymes.
In lysosomal storage disorders, the cell is unable to produce an enzyme responsible for the breakdown of large molecules which leads to cell death.
* Meikle, PJ et al, Prevalence of Lysosomal Storage Disorders, JAMA 1999; 281:249-254
National Tay-Sachs & Allied Diseases Association
2001 Beacon Street
Suite 204
Boston, MA 02135
info@ntsad.org
800-906-8723 phone
617-277-0134 fax
Genetic Allicance
www.geneticalliance.org
Rare Diseases
www.rarediseases.org
Neurological Disorders
www.ninds.nih.gov
Biotechnology Info
www.ncbi.nlm.nih.gov
The Organization
Home
About NTSAD
Mission & Vision
Board of Directors
Staff & Profiles
Chapters & Affiliates
Scientific Advisory Committee
Financials
Our History
News
Library Documents
Glossary
Contact
Search
Member Login
The Diseases
Tay SachsFind Support
Annual Family ConferenceResearch
Potential Therapies